Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' Equity

v3.22.2.2
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Common Shares
Additional Paid-in Capital
Warrants
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Controlling Interest
Total
Balance at beginning of period at Dec. 31, 2020 $ 851,851 $ 223,499 $ 6,757 $ 1,014 $ (818,436)   $ 264,685
Balance at beginning of period (in shares) at Dec. 31, 2020 367,182,673            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   625         625
Warrants exercised $ 149           149
Warrants exercised (in shares) 567,000            
Warrants reclassified to liability     (5,805)   (2,686)   (8,491)
Issuance and vesting of restricted share units $ 257           257
Issuance and vesting of restricted share units (in shares) 825,000            
Comprehensive income (loss) for the period       (2) (17,057)   (17,059)
Balance at end of the period at Mar. 31, 2021 $ 852,257 224,124 952 1,012 (838,179)   240,166
Balance at end of period (in shares) at Mar. 31, 2021 368,574,673            
Balance at beginning of period at Dec. 31, 2020 $ 851,851 223,499 6,757 1,014 (818,436)   264,685
Balance at beginning of period (in shares) at Dec. 31, 2020 367,182,673            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss) for the period             (15,010)
Balance at end of the period at Sep. 30, 2021 $ 853,651 224,739 952 1,001 (836,119) $ 175 244,399
Balance at end of period (in shares) at Sep. 30, 2021 372,309,553            
Balance at beginning of period at Mar. 31, 2021 $ 852,257 224,124 952 1,012 (838,179)   240,166
Balance at beginning of period (in shares) at Mar. 31, 2021 368,574,673            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss) for the period       (7) 1,034   1,027
Balance at end of the period at Jun. 30, 2021 $ 852,257 224,124 952 1,005 (837,145)   241,193
Balance at end of period (in shares) at Jun. 30, 2021 368,574,673            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Options exercised $ 13           13
Options exercised (Shares) 221,400            
Share-based compensation   519         519
Warrants exercised $ 24 96         120
Warrants exercised (in shares) 90,000            
Issuance and vesting of restricted share units $ 898           898
Issuance and vesting of restricted share units (in shares) 2,674,104            
Shares reserved for contingent consideration $ 108           108
Shares issued from formation of SFNY $ 351           351
Shares issued from formation of SFNY (Shares) 749,376            
Non-controlling interest           175 175
Comprehensive income (loss) for the period       (4) 1,026   1,022
Balance at end of the period at Sep. 30, 2021 $ 853,651 224,739 952 1,001 (836,119) 175 244,399
Balance at end of period (in shares) at Sep. 30, 2021 372,309,553            
Balance at beginning of period at Dec. 31, 2021 $ 854,952 224,835 952 999 (856,248) 175 225,665
Balance at beginning of period (in shares) at Dec. 31, 2021 374,082,759            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   81         81
Issuance and vesting of restricted share units $ 888           888
Issuance and vesting of restricted share units (in shares) 1,220,468            
Shares reserved for contingent consideration $ 257           257
Comprehensive income (loss) for the period       1 (11,629) (5) (11,633)
Balance at end of the period at Mar. 31, 2022 $ 856,097 224,916 952 1,000 (867,877) 170 215,258
Balance at end of period (in shares) at Mar. 31, 2022 375,303,227            
Balance at beginning of period at Dec. 31, 2021 $ 854,952 224,835 952 999 (856,248) 175 225,665
Balance at beginning of period (in shares) at Dec. 31, 2021 374,082,759            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss) for the period             (34,389)
Balance at end of the period at Sep. 30, 2022 $ 857,413 224,921 952 989 (890,619) 167 193,823
Balance at end of period (in shares) at Sep. 30, 2022 375,776,275            
Balance at beginning of period at Mar. 31, 2022 $ 856,097 224,916 952 1,000 (867,877) 170 215,258
Balance at beginning of period (in shares) at Mar. 31, 2022 375,303,227            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   18         18
Issuance and vesting of restricted share units $ 508           508
Issuance and vesting of restricted share units (in shares) 473,048            
Shares reserved for contingent consideration $ 261           261
Comprehensive income (loss) for the period       (3) (7,051) (3) (7,057)
Balance at end of the period at Jun. 30, 2022 $ 856,866 224,934 952 997 (874,928) 167 208,988
Balance at end of period (in shares) at Jun. 30, 2022 375,776,275            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   (13)         (13)
Issuance and vesting of restricted share units $ 430           430
Shares reserved for contingent consideration 117           117
Comprehensive income (loss) for the period       (8) (15,691)   (15,699)
Balance at end of the period at Sep. 30, 2022 $ 857,413 $ 224,921 $ 952 $ 989 $ (890,619) $ 167 $ 193,823
Balance at end of period (in shares) at Sep. 30, 2022 375,776,275